USP14 stabilizes BAG4 by deubiquitination, which subsequently inhibits Parkin-mediated mitophagy, promotes tumorigenesis, and decreases the sensitivity of CRC (MSI-H) cells to oxaliplatin chemotherapy. Here, USP14 is linked to colorectal carcinoma.